45 participants
A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2025-12-24
- Completion:
- 2028-06-22
Conditions
- Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions
- DRUG
No Results Yet